rs17097468

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_004086.3(COCH):​c.1553A>G​(p.Glu518Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00111 in 1,613,950 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. E518E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0057 ( 13 hom., cov: 33)
Exomes 𝑓: 0.00064 ( 12 hom. )

Consequence

COCH
NM_004086.3 missense

Scores

7
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 6.93

Publications

7 publications found
Variant links:
Genes affected
COCH (HGNC:2180): (cochlin) The protein encoded by this gene is highly conserved in human, mouse, and chicken, showing 94% and 79% amino acid identity of human to mouse and chicken sequences, respectively. Hybridization to this gene was detected in spindle-shaped cells located along nerve fibers between the auditory ganglion and sensory epithelium. These cells accompany neurites at the habenula perforata, the opening through which neurites extend to innervate hair cells. This and the pattern of expression of this gene in chicken inner ear paralleled the histologic findings of acidophilic deposits, consistent with mucopolysaccharide ground substance, in temporal bones from DFNA9 (autosomal dominant nonsyndromic sensorineural deafness 9) patients. Mutations that cause DFNA9 have been reported in this gene. Alternative splicing results in multiple transcript variants encoding the same protein. Additional splice variants encoding distinct isoforms have been described but their biological validities have not been demonstrated. [provided by RefSeq, Oct 2008]
COCH Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss 9
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive 110
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in NM_004086.3
BP4
Computational evidence support a benign effect (MetaRNN=0.0071074963).
BP6
Variant 14-30889691-A-G is Benign according to our data. Variant chr14-30889691-A-G is described in ClinVar as Benign. ClinVar VariationId is 162972.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00565 (861/152280) while in subpopulation AFR AF = 0.0191 (793/41550). AF 95% confidence interval is 0.018. There are 13 homozygotes in GnomAd4. There are 412 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COCHNM_004086.3 linkc.1553A>G p.Glu518Gly missense_variant Exon 12 of 12 ENST00000396618.9 NP_004077.1 O43405-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COCHENST00000396618.9 linkc.1553A>G p.Glu518Gly missense_variant Exon 12 of 12 1 NM_004086.3 ENSP00000379862.3 O43405-1

Frequencies

GnomAD3 genomes
AF:
0.00561
AC:
853
AN:
152162
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0189
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00153
AC:
384
AN:
251326
AF XY:
0.00123
show subpopulations
Gnomad AFR exome
AF:
0.0209
Gnomad AMR exome
AF:
0.000636
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000641
AC:
937
AN:
1461670
Hom.:
12
Cov.:
31
AF XY:
0.000573
AC XY:
417
AN XY:
727146
show subpopulations
African (AFR)
AF:
0.0205
AC:
686
AN:
33476
American (AMR)
AF:
0.00103
AC:
46
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86256
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53416
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000612
AC:
68
AN:
1111834
Other (OTH)
AF:
0.00185
AC:
112
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00565
AC:
861
AN:
152280
Hom.:
13
Cov.:
33
AF XY:
0.00553
AC XY:
412
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0191
AC:
793
AN:
41550
American (AMR)
AF:
0.00320
AC:
49
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68012
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
42
85
127
170
212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00188
Hom.:
6
Bravo
AF:
0.00650
ESP6500AA
AF:
0.0186
AC:
82
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00196
AC:
238
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glu518Gly in Exon 12 of COCH: This variant is not expected to have clinical sign ificance because it has been identified in 2.0% (75/3738) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs17097468). -

Autosomal dominant nonsyndromic hearing loss 9 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.18
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.39
.;T;T;T;T
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.88
D;.;.;D;D
MetaRNN
Benign
0.0071
T;T;T;T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
2.0
.;M;M;.;M
PhyloP100
6.9
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-2.8
.;D;.;D;.
REVEL
Uncertain
0.52
Sift
Benign
0.15
.;T;.;D;.
Sift4G
Benign
0.074
.;T;.;T;.
Polyphen
0.82
.;P;P;.;P
Vest4
0.35, 0.39
MVP
0.91
MPC
0.41
ClinPred
0.024
T
GERP RS
5.2
Varity_R
0.22
gMVP
0.65
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17097468; hg19: chr14-31358897; API